Even though the direct effect of ACE2 on these biomarkers levels is not quite clear, the difference showed in these COVID-19-associated biomarkers supports the notion that ACE2 rs228566 polymorphism could be consider as a genetic susceptibility marker for COVID-19 outcome. This evidence concerns the gene ACE2 and COVID-19.